Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-11
1999-03-16
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514456, A61K 3140, A61K 3135
Patent
active
058831185
ABSTRACT:
The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
REFERENCES:
patent: 5280040 (1994-01-01), Labroo et al.
patent: 5453442 (1995-09-01), Bryant et al.
Smith, J.A., Review Article, The Journal of Urology, vol. 137, pp. 1-10, 1987.
Dhar, J. D. et al., Andrologia 15 No. 5, pp. 463-467 (1983).
Drugs of the Future, vol. 15, No. 7, p. 734 (1990).
Smith, J.A., Review Article, The Journal of Urology, vol. 137, pp. 1-10, 1987.
Christensen Niels Dyhr
Guldhammer Birgitte Hjort
Korsgaard Niels
Shalmi Michael
Goldberg Jerome D.
Lambiris Elias J.
Nova Nordisk A/S
Zelson Steve T.
LandOfFree
Prostatic carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostatic carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostatic carcinoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-818061